Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Product sales, net $ 3,195 $ 3,606
Revenue, product and service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Cost of goods sold $ 1,633 $ 1,948
Gross profit 1,562 1,658
Operating expenses:    
Research and development 18 30
Selling, general and administrative 1,862 2,139
Benefit from reversal of accrued payroll taxes (Note 11) 0 (522)
Total operating expenses 1,880 1,647
Operating income (loss) (318) 11
Gain on extinguishment of debt (20) (38)
Change in fair value of convertible notes payable 252 0
Interest expense, net 93 151
Loss before income taxes (643) (102)
Income tax expense 0 7
Net loss $ (643) $ (109)
Weighted average common shares outstanding, basic (in shares) 186,920 184,264
Weighted average common shares outstanding, diluted (in shares) 186,920 184,264
Net loss per common share, basic (in USD per share) $ (0) $ (0)
Net loss per common share, basic diluted (in USD per share) $ (0) $ (0)